Hinge Health initiated with an Outperform at RBC Capital

RBC Capital initiated coverage of Hinge Health (HNGE) with an Outperform rating and $45 price target The firm has confidence in the company’s category leadership, margin expansion potential, and long-term growth runway. With 20M covered lives, strong employer traction, and expanding clinical validation, Hinge is best positioned to scale digital musculoskeletal care, the analyst tells investors in a research note. RBC sees upside from Hinge’s further penetration into commercial, Medicare Advantage, and international markets.